ангиотензин转化酶插入/删除基因型,运动和身体衰退
Stephen B Kritchevsky1, Barbara J Nicklas, Marjolein Visser
1The Sticht Center on Aging and Center for Human Genomics, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA. skritche@wfubmc.edu
JAMA
|August 11, 2005
概括
身体活动可以减少老年人的运动限制. 然而,血管激素转化酶 (ACE) 基因型影响了这一益处,II基因型在活跃个体中显示风险增加.
科学领域:
- 老年学是指老年学的学科.
- 遗传学 是一个遗传学.
- 运动生理学 运动生理学
背景情况:
- 血管激素转化酶 (ACE) 插入 (I) /删除 (D) 基因型与年轻成年人的身体表现有关.
- 它在老年人运动反应和运动限制中的作用仍未得到充分研究.
研究的目的:
- 研究ACE基因型与体力活动之间的相互作用,以预测功能良好老年人的运动限制.
主要方法:
- 健康衰老和身体组成 (Health ABC) 研究招募了3075名70-79岁的成年人.
- 运动限制被定义为难以行走0.4公里或爬10个台阶.
- 随访时间平均为4.1年.
主要成果:
- 身体活动 (>1000卡路里/周) 减少了不论ACE基因型的运动限制风险.
- 观察到ACE基因型和体育活动之间的显著相互作用 (P = .002).
- 在活跃的参与者中,与ID/DD基因型相比,ACE II基因型与移动性限制的风险更高 (调整率比,1.45),特别是举重.
结论:
- 与II基因型相比,具有ACE DD或ID基因型的老年人运动的运动限制的风险较低.
- 在所有ACE基因型中,运动始终降低了运动限制风险.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...


